1. 3227 A phase II trial of ofatumumab for mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) - An interim analysis. (September 2015) Authors: Kiesewetter, B.; Mayerhoefer, M.E.; Dolak, W.; Simonitsch-Klupp, I.; Lukas, J.; Raderer, M. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FIRST LINE SYSTEMIC TREATMENT IN MUCOSA‐ASSOCIATED LYMPHOID TISSUE (MALT) LYMPHOMA NOT ELIGIBLE FOR H. PYLORI ERADICATION – DO WE NEED CHEMOTHERAPY?. (12th June 2019) Authors: Kiesewetter, B.; Lamm, W.; Mayerhoefer, M.E.; Dolak, W.; Lukas, J.; Simonitsch‐Klupp, I.; Raderer, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 449 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PROGRESSION‐FREE SURVIVAL FOLLOWING LENALIDOMIDE‐BASED TREATMENT IS SIGNIFICANTLY LONGER IN EXTRAGASTRIC THAN IN GASTRIC MARGINAL ZONE B‐CELL LYMPHOMA OF THE MUCOSA‐ASSOCIATED LYMPHOID TISSUE LYMPHOMA (MALT LYMPHOMA). (June 2017) Authors: Kiesewetter, B.; Mayerhoefer, M.E.; Dolak, W.; Lukas, J.; Simonitsch‐Klupp, I.; Raderer, M. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 212 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. TRANSFORMED MUCOSA‐ASSOCIATED LYMPHOID TISSUE LYMPHOMAS: A SINGLE INSTITUTION RETROSPECTIVE STUDY INCLUDING PCR‐BASED CLONALITY ANALYSIS. (12th June 2019) Authors: Kiesewetter, B.; Lamm, W.; Dolak, W.; Lukas, J.; Mayerhoefer, M.E.; Weber, M.; Kornauth, C.; Schiefer, A.I.; Bayer, G.; Simonitsch‐Klupp, I.; Raderer, M. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 264 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗